Dr. Salil Patkar

Oncologist & Hemato-Oncologist, Immuno-Oncologist

MD Internal Medicine, DM Medical Oncology, Certified in Immuno-Oncology and Precision Oncology (Harvard Medical School)

Dr. Salil Vijay Patkar is a senior Medical Oncologist with over 12 years of extensive clinical experience, specialising in the comprehensive management of solid tumors and hematological malignancies. He is the Founder and Director of the Indian Cancer Treatment Centre (ICTC), an institution established with the vision of delivering evidence-based, modern, and patient-centric cancer care through a network of centres across Mumbai. Dr. Patkar completed his MD in Internal Medicine from KLES University’s Jawaharlal Nehru Medical College and Dr. Prabhakar Kore Hospital, followed by a DM in Medical Oncology from the Gujarat Cancer & Research Institute (GCRI), Ahmedabad, one of India’s most respected and high-volume comprehensive cancer centres. His training at GCRI provided in-depth exposure to complex oncological cases, multidisciplinary tumour boards, protocol-driven cancer management, and advanced chemotherapy and immunotherapy practices. To further strengthen his expertise in advanced cancer therapeutics, Dr. Patkar completed a Certificate Program in Cancer Genomics, Precision Oncology, and Immuno-Oncology from Harvard Medical School. This training equipped him with a strong foundation in molecular diagnostics, targeted therapies, and personalised treatment planning. He has also pursued a postgraduate academic program affiliated with Johns Hopkins School of Medicine, reflecting his commitment to continuous learning and global medical education standards. Clinically, Dr. Patkar has deep expertise in immunotherapy, molecular-targeted therapy, chemotherapy, and precision oncology, enabling him to design individualised treatment plans based on tumour biology, genetic markers, and patient-specific factors. He is also skilled in performing bone marrow aspiration and biopsy and is actively involved in the management of both hematological cancers and solid tumours. Prior to founding ICTC, Dr. Patkar held several leadership and consultant roles at prominent healthcare institutions. He served as the Head of the Medical Oncology Department at MPCT Hospitals and has worked as a Consultant Medical Oncologist at Apollo Hospitals, gaining extensive experience across institutional oncology programs and private cancer care delivery. In addition to his clinical work, Dr. Patkar has contributed to oncology research and academic initiatives. He was a Co-investigator in the PROMISE clinical registry at GCRI, focusing on diffuse large B-cell lymphoma and chronic lymphocytic leukemia. He has authored and co-authored clinical case reports and studies, including work on rare cancer presentations and colorectal cancer clinical profiles. Dr. Patkar’s professional excellence has been recognised through multiple academic and professional awards, including Student of the Year (Delcure Lifesciences, 2013) and First Prize in the Lung Cancer Quiz at GCRI (2017). He is widely respected for his structured clinical approach, strong patient communication skills, and unwavering commitment to ethical oncology practice. As the Founder and Director of ICTC, Dr. Patkar continues to lead a multidisciplinary oncology team focused on delivering high-quality cancer care using globally aligned treatment protocols. His work reflects a balance of advanced science, clinical precision, and compassionate care, ensuring that patients receive timely, transparent, and effective oncology treatment close to home.

My approach to oncology care is rooted in empathy, transparency, and evidence-based medicine. I believe that every patient deserves an individualised treatment plan guided by tumour biology, molecular profiling, and global clinical guidelines. Clear communication, ethical practice, and compassionate care remain central to my work, ensuring patients and their families are fully informed and supported throughout their cancer journey.